Comparative Responses to 15 Different Antidepressants in Major Depressive Disorder
NCT ID: NCT05952713
Last Updated: 2023-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
73336 participants
OBSERVATIONAL
2022-10-01
2023-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcome Following Antidepressant Treatment on Possible Endo-Phenotypes for Major Depression
NCT00386841
This is a Study to Determine the Antidepressant Effects of AZD6765
NCT00986479
A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression
NCT01098240
Treatment Outcome in Major Depressive Disorder
NCT02869035
The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
NCT05973851
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SSRI
Group 1: Selective serotonin reuptake inhibitors (reference: sertraline)
Comparisons of the following with sertraline:
Citalopram, Fluoxetine, Paroxetine, Escitalopram
Antidepressant
Treatment with an antidepressant according to Danish register data.
NARI
Group 2: Noradrenaline reuptake inhibitors (reference: sertraline) Comparisons of the following with sertraline: Reboxetine
Antidepressant
Treatment with an antidepressant according to Danish register data.
SNRI
Group 3: Serotonin and noradrenaline reuptake inhibitors (reference: venlafaxine) Comparisons of Duloxetine with venlafaxine
Antidepressant
Treatment with an antidepressant according to Danish register data.
ARI
Group 4: Adrenergic receptor inhibitors (reference: Mirtazapine) Comparisons of Mianserin with Mirtazapine
Antidepressant
Treatment with an antidepressant according to Danish register data.
Other drugs
Group 5: Other drugs (reference: sertraline) Comparisons of Vortioxetine and Agomelatine with sertraline
Antidepressant
Treatment with an antidepressant according to Danish register data.
TCA
Group 6: Tricyclic antidepressants (reference: amitriptyline)
Comparisons of Nortriptyline, Imipramine, Clomipramine and Dosulepin with amitriptyline
Antidepressant
Treatment with an antidepressant according to Danish register data.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antidepressant
Treatment with an antidepressant according to Danish register data.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Copenhagen
OTHER
Mental Health Services in the Capital Region, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Psychiatric Center Copenhagen
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MHSCRDenmark_2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.